当前位置: X-MOL 学术Int. Immunopharmacol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Sesquiterpene lactone Zaluzanin D alters MMP-9 promoter methylation in differentiated THP-1 monocytic cells and down regulates inflammatory cytokines IL-1β and TNF-α.
International Immunopharmacology ( IF 4.8 ) Pub Date : 2020-07-29 , DOI: 10.1016/j.intimp.2020.106803
Vinnie Cheeran 1 , Ganesh Munuswamy-Ramanujam 2
Affiliation  

Zaluzanin D (ZD) is a sesquiterpene lactone isolated from the leaves of Vernonia arborea. Earlier studies have highlighted the Sesquiterpene lactones (SLs) as molecules of medicinal value. The current study investigates the anti-inflammatory potential of ZD and its biotransformed derivatives in PMA differentiated human monocytic THP-1 cells. ZD and its fungal biotransformed derivatives Zaluzanin C (ZC) and 11,13- dihydrozaluzanin C (DZC) were screened for anti-inflammatory activity using their IC50 concentration. ZD showed significant ability to reduce PMA mediated THP-1 activation, while both ZC and DZC did not show any anti-inflammatory activity. Further studies revealed that ZD had ability to attenuate intracellular reactive oxygen species production in THP-1 cells as confirmed with FACS and fluorescence microscope experiments. Similarly, Oil red O (ORO) assay showed ability of ZD to inhibit lipid accumulation in monocytes. ZD also significantly reduced the expression of pro-inflammatory markers, tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, MMP (Matrix metalloproteinases)-9 and MMP-2 as observed with RT-PCR and ELISA. Interestingly the molecule ZD also partially reversed DNA methylation levels in the PMA activated THP-1 cells. This indicated the ability of ZD to influence the epigenetic machinery of the cell. Overall the current study indicates that ZD has ability to attenuate inflammation in differentiated human THP-1 cells by regulating genes involved in the atherosclerosis inflammatory pathway. Thus ZD could potentially be used to modulate inflammation in atherosclerosis like disorders wherein monocytes play a key role.



中文翻译:

倍半萜内酯Zaluzanin D改变分化的THP-1单核细胞中MMP-9启动子的甲基化,并下调炎性细胞因子IL-1β和TNF-α。

Zaluzanin D(ZD)是一种从倍叶草Vernonia的叶中分离出的倍半萜内酯早期的研究强调了倍半萜内酯(SLs)具有药用价值。目前的研究调查了ZD及其生物转化衍生物在PMA分化的人单核THP-1细胞中的抗炎潜力。使用其IC 50对ZD及其真菌生物转化的衍生物Zaluzanin C(ZC)和11,13-二氢Zaluzanin C(DZC)进行了抗炎活性筛选浓度。ZD显示出降低PMA介导的THP-1激活的显着能力,而ZC和DZC均未显示任何抗炎活性。进一步的研究表明,如FACS和荧光显微镜实验所证实的,ZD具有减弱THP-1细胞中细胞内活性氧产生的能力。同样,油红O(ORO)分析显示ZD抑制单核细胞中脂质蓄积的能力。与RT-PCR和ELISA相比,ZD还显着降低了促炎标记,肿瘤坏死因子-α(TNF-α),白介素(IL)-1β,MMP(基质金属蛋白酶)-9和MMP-2的表达。有趣的是,分子ZD还可以部分逆转PMA激活的THP-1细胞中的DNA甲基化水平。这表明ZD影响细胞表观遗传机制的能力。总的来说,当前的研究表明,ZD具有通过调节参与动脉粥样硬化炎症途径的基因来减轻分化的人类THP-1细胞炎症的能力。因此,ZD可能潜在地用于调节动脉粥样硬化样疾病(其中单核细胞起关键作用)的炎症。

更新日期:2020-07-29
down
wechat
bug